Progress in Arrhythmia

• Other Authors: Rivera-Caravaca, José Miguel (Editor)
• Format: Electronic Book Chapter
• Language: English
• Published: MDPI - Multidisciplinary Digital Publishing Institute 2023
• Subjects: Medicine; atrial fibrillation; catheter ablation; coronary sinus; catheter channels; P-waves; local activation waves; left pulmonary veins; heart rate variability; vitamin K antagonists; time in therapeutic range; Atrial Fibrillation Better Care (ABC) pathway; anticoagulant; left atrial appendage occlusion; cardiovascular disease; hemophilia; atrial fibrillation detection; cardiac arrhythmia; stroke prevention; electrocardiogram; sensor devices; community screening; rehabilitation medicine; physical activity; exercise; preventive cardiology; vascular health; atrial health; secondary prevention; all-cause mortality; phenotype; risk factors; finite element method; atrophy; fibrosis; biomarkers; NT-proBNP; electrogram; complex fractionated atrial electrograms; detection; invasive recordings; cycle length; comparison; persistent atrial fibrillation; outcome prediction; fibrillatory wave analysis; spectral analysis; dominant frequency; harmonic content; n/a
• Online Access: DOAB: download the publication; DOAB: description of the publication

This Special Issue focuses on novel and scarcely investigated topics in relation to atrial fibrillation (AF), from the role of f-wave harmonic spectral structures in improving the preoperative prediction of catheter ablation outcomes in AF to the design of a study to investigate the effectiveness of a hand-held device in screening for AF when embedded into the handles of supermarket trolleys. However, the management of AF is so complex that this Special Issue also explores the therapeutic approach to AF in patients with congenital hemophilia, provides exercise recommendations for patients with AF, and includes broader investigations, such as on the impact of integrated care on oral anticoagulation quality, the identification of clinical phenotypes to stratify mortality risk, and the assessment of differences in biomarkers between AF patients and healthy controls.